AU2001269478A1 - Hyaluronic acid oligosaccharide fractions and drugs containing the same - Google Patents

Hyaluronic acid oligosaccharide fractions and drugs containing the same

Info

Publication number: AU2001269478A1
Authority: AU; Australia
Prior art keywords: same; hyaluronic acid; drugs containing; acid oligosaccharide; oligosaccharide fractions
Prior art date: 2000-07-07
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Granted

Application number

AU2001269478A

Other versions

AU2001269478B2 (en

Inventor

Akira Asari

Tomomi Ito

Hitoshi Kurihara

Takahiro Masa

Yuji Matsuzaki

Yuka Miyazaki

Akira Tawada

Hiroko Yamanokuchi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Seikagaku Corp

Original Assignee

Seikagaku Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-07-07

Filing date

2001-07-06

Publication date

2002-04-18

2001-07-06 Application filed by Seikagaku Corp filed Critical Seikagaku Corp

2001-07-06 Priority claimed from PCT/JP2001/005918 external-priority patent/WO2002004471A1/en

2002-04-18 Publication of AU2001269478A1 publication Critical patent/AU2001269478A1/en

2006-09-21 Application granted granted Critical

2006-09-21 Publication of AU2001269478B2 publication Critical patent/AU2001269478B2/en

2006-12-21 Priority to AU2006252178A priority Critical patent/AU2006252178B2/en

2021-07-06 Anticipated expiration legal-status Critical

Status Ceased legal-status Critical Current

Links

239000003814 drug Substances 0.000 title 1
229940079593 drugs Drugs 0.000 title 1
229920002674 hyaluronan Polymers 0.000 title 1
229960003160 hyaluronic acid Drugs 0.000 title 1
229920001542 oligosaccharide Polymers 0.000 title 1
150000002482 oligosaccharides Polymers 0.000 title 1
MAKUBRYLFHZREJ-JWBQXVCJSA-M sodium;(2S,3S,4R,5R,6R)-3-[(2S,3R,5S,6R)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylate Chemical compound [Na+].CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C([O-])=O)O[C@@H](O)[C@H](O)[C@H]1O MAKUBRYLFHZREJ-JWBQXVCJSA-M 0.000 title 1

AU2001269478A 2000-07-07 2001-07-06 Hyaluronic acid oligosaccharide fractions and drugs containing the same Ceased AU2001269478B2 (en)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
AU2006252178A AU2006252178B2 (en)	2000-07-07	2006-12-21	Hyaluronic acid oligosaccharide fractions and drugs containing the same

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
JP2000206404		2000-07-07
JP2000-206404		2000-07-07
JP2000-247840		2000-08-17
JP2000247840		2000-08-17
PCT/JP2001/005918 WO2002004471A1 (en)	2000-07-07	2001-07-06	Hyaluronic acid oligosaccharide fractions and drugs containing the same

Related Child Applications (1)

Application Number	Title	Priority Date	Filing Date
AU2006252178A Division AU2006252178B2 (en)	2000-07-07	2006-12-21	Hyaluronic acid oligosaccharide fractions and drugs containing the same

Publications (2)

Publication Number	Publication Date
AU2001269478A1 true AU2001269478A1 (en)	2002-04-18
AU2001269478B2 AU2001269478B2 (en)	2006-09-21

Family

ID=26595584

Family Applications (3)

Application Number	Title	Priority Date	Filing Date
AU6947801A Pending AU6947801A (en)	2000-07-07	2001-07-06	Hyaluronic acid oligosaccharide fractions and drugs containing the same
AU2001269478A Ceased AU2001269478B2 (en)	2000-07-07	2001-07-06	Hyaluronic acid oligosaccharide fractions and drugs containing the same
AU2006252178A Ceased AU2006252178B2 (en)	2000-07-07	2006-12-21	Hyaluronic acid oligosaccharide fractions and drugs containing the same

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
AU6947801A Pending AU6947801A (en)	2000-07-07	2001-07-06	Hyaluronic acid oligosaccharide fractions and drugs containing the same

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
AU2006252178A Ceased AU2006252178B2 (en)	2000-07-07	2006-12-21	Hyaluronic acid oligosaccharide fractions and drugs containing the same

Country Status (9)

Country	Link
US (5)	US7507723B2 (en)
EP (1)	EP1300412B1 (en)
JP (1)	JP4861596B2 (en)
CN (1)	CN100369925C (en)
AT (1)	ATE453655T1 (en)
AU (3)	AU6947801A (en)
CA (2)	CA2698561C (en)
DE (1)	DE60140941D1 (en)
WO (1)	WO2002004471A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7511026B2 (en) *	2003-03-25	2009-03-31	Seikagaku Corporation	Therapeutic agent for nerve damage
JP4576583B2 (en)	2005-03-22	2010-11-10	キユーピー株式会社	Hyaluronic acid or a salt thereof, method for producing the same, and cosmetics and food compositions containing the same
JP2007084509A (en) *	2005-09-26	2007-04-05	Toshitsu Kagaku Kenkyusho:Kk	Cell activator
JP2007153761A (en) *	2005-12-01	2007-06-21	Toshitsu Kagaku Kenkyusho:Kk	Synapse transmission promoter and synapse protective agent
US20070099867A1 (en) *	2005-05-24	2007-05-03	Glycoscience Laboratories, Inc.	Pharmaceutical agent containing hyaluronan as an active ingredient
CA2560844C (en) *	2005-09-26	2011-05-17	Glycoscience Laboratories, Inc.	Pharmaceutical agent containing hyaluronan as an active ingredient
JP2009091248A (en) *	2006-01-17	2009-04-30	Toshitsu Kagaku Kenkyusho:Kk	Therapeutic agent for traumatic neuropathy and/or motor function disorder
KR101482800B1 (en) *	2006-02-24	2015-01-14	큐피가부시키가이샤	Novel low molecular weight hyaluronic acid and/or salt thereof, and cosmetic preparation, pharmaceutical composition, and food composition each using same
WO2008047779A1 (en) *	2006-10-17	2008-04-24	Glycoscience Laboratories, Inc.	Therapeutic or prophylactic agent for atopic dermatitis
US8153614B2 (en)	2006-12-05	2012-04-10	Glycoscience Laboratories, Inc.	Treatment of osteoarthritis
WO2009046530A1 (en) *	2007-10-12	2009-04-16	London Health Sciences Centre Research Inc.	Compositions affecting hyaluronic acid mediated activity
CN101326963B (en) *	2008-03-03	2011-06-22	北京神州圣业科技有限公司	Alkaline kation feed immunopotentiator solution, production method and uses thereof
JPWO2009113512A1 (en) *	2008-03-11	2011-07-21	キユーピー株式会社	SOCS3 expression promoter, pharmaceutical and food containing the same, and method for promoting SOCS3 expression
TW201031749A (en)	2009-02-10	2010-09-01	Otsuka Chemical Co Ltd	IgG-Fc fragment and method for manufacturing the same
JP5587637B2 (en) *	2009-04-10	2014-09-10	生化学工業株式会社	Matrix metalloprotease inhibitors and uses thereof
SG11201404959TA (en)	2012-02-22	2014-11-27	Hyaluronan Res Inst Inc	Sirtuin inducer, tissue repairing agent, hepatocyte growth factor inducer, tissue homeostasis maintenance agent, and tlr4 agonist, having hyaluronic acid fragment as active agent
EP2698636A1 (en) *	2012-08-13	2014-02-19	Fundació Institut d'Investigació Biomèdica de Bellvitge	Methods and reagents for prevention and/or treatment of transplant rejection
US10723812B2 (en) *	2014-02-06	2020-07-28	New York University	Method for separating hyaluronan and quantifying its molecular mass distribution in biological samples
KR20180028787A (en) *	2016-09-09	2018-03-19	삼성전자주식회사	Defect inspection system and method, and method for fabricating semiconductor using the inspection method
CN110446511B (en)	2017-03-10	2024-04-02	北卡罗来纳大学查珀尔希尔分校	Short acting heparin-based anticoagulant compounds and methods
JP7285048B2 (en) *	2017-03-31	2023-06-01	ロート製薬株式会社	Method for producing composition containing hyaluronic acid oligosaccharide
US11993627B2 (en)	2017-07-03	2024-05-28	The University Of North Carolina At Chapel Hill	Enzymatic synthesis of homogeneous chondroitin sulfate oligosaccharides
EP3691653A4 (en)	2017-11-03	2021-08-11	The University Of North Carolina At Chapel Hill	Sulfated oligosaccharides having anti-inflammatory activity
US11633424B2 (en)	2018-06-20	2023-04-25	The University Of North Carolina At Chapel Hill	Cell protective methods and compositions
CN109517012B (en) *	2018-11-13	2020-05-22	华熙生物科技股份有限公司	Preparation method of hyaluronic acid oligosaccharide
CN109528753B (en) *	2018-12-20	2021-01-22	四川大学华西医院	Application of oligomeric hyaluronic acid or salt thereof in preparation of medicine for treating myocardial infarction
CN113876623B (en) *	2021-09-24	2024-06-14	华熙生物科技股份有限公司	Application of hyaluronic acid oligosaccharide composition in resisting skin aging and promoting collagen production
CN115774066B (en) *	2022-11-16	2024-08-27	南京乐韬生物科技有限公司	Method for analyzing component proportion of ultra-low molecular weight hyaluronic acid

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4141973A (en) *	1975-10-17	1979-02-27	Biotrics, Inc.	Ultrapure hyaluronic acid and the use thereof
JPH06107538A (en) *	1992-03-31	1994-04-19	Shiseido Co Ltd	Bulb of eye preserving solution for cornea graft
US5902795A (en) *	1992-06-16	1999-05-11	Trustees Of Tufts College	Oligosaccharides reactive with hyaluronan-binding protein and their methods of use
US5616568A (en) *	1993-11-30	1997-04-01	The Research Foundation Of State University Of New York	Functionalized derivatives of hyaluronic acid
JP4195107B2 (en) *	1996-02-16	2008-12-10	生化学工業株式会社	Stress protein expression enhancer
IT1287227B1 (en) *	1996-04-04	1998-08-04	Fidia Spa In Amministrazione S	HYALURONIC ACID AS A COMPONENT OF THE CORNEA PRESERVATION LIQUID
JPH11246301A (en)	1998-02-27	1999-09-14	Denki Kagaku Kogyo Kk	Organ preserving solution
US6613897B1 (en) *	1998-04-30	2003-09-02	Maruha Corporation	Compounds having glucuronic acid derivatives and glucosamine derivative in the structure, process for producing the same and utilization thereof
JP4301602B2 (en)	1998-09-28	2009-07-22	株式会社マルハニチロ水産	Vascular endothelial cell growth promoter
JP4301591B2 (en)	1998-04-30	2009-07-22	株式会社マルハニチロ水産	Novel platelet adhesion aggregation inhibitor, its production method and its use
US7511026B2 (en) *	2003-03-25	2009-03-31	Seikagaku Corporation	Therapeutic agent for nerve damage

2001
- 2001-07-06 WO PCT/JP2001/005918 patent/WO2002004471A1/en active Application Filing
- 2001-07-06 AU AU6947801A patent/AU6947801A/en active Pending
- 2001-07-06 JP JP2002509334A patent/JP4861596B2/en not_active Expired - Fee Related
- 2001-07-06 EP EP01947909A patent/EP1300412B1/en not_active Expired - Lifetime
- 2001-07-06 AU AU2001269478A patent/AU2001269478B2/en not_active Ceased
- 2001-07-06 AT AT01947909T patent/ATE453655T1/en not_active IP Right Cessation
- 2001-07-06 CA CA2698561A patent/CA2698561C/en not_active Expired - Fee Related
- 2001-07-06 CN CNB018124321A patent/CN100369925C/en not_active Expired - Fee Related
- 2001-07-06 US US10/312,879 patent/US7507723B2/en not_active Expired - Fee Related
- 2001-07-06 DE DE60140941T patent/DE60140941D1/en not_active Expired - Lifetime
- 2001-07-06 CA CA2414211A patent/CA2414211C/en not_active Expired - Fee Related
2006
- 2006-12-21 AU AU2006252178A patent/AU2006252178B2/en not_active Ceased
2007
- 2007-01-12 US US11/622,673 patent/US7601488B2/en not_active Expired - Fee Related
- 2007-10-30 US US11/928,833 patent/US20080182983A1/en not_active Abandoned
2009
- 2009-05-27 US US12/472,479 patent/US20090291914A1/en not_active Abandoned
2011
- 2011-05-25 US US13/115,435 patent/US8314079B2/en not_active Expired - Fee Related

Publication	Publication Date	Title
AU2001269478A1 (en)	2002-04-18	Hyaluronic acid oligosaccharide fractions and drugs containing the same
AU2001290257A1 (en)	2002-06-27	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2001290257A2 (en)	2003-05-01	Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
AU2002306269A1 (en)	2003-05-15	N-arylphenylacetamide derivatives and pharmaceutical composition containing the same
AU2001256184A1 (en)	2001-09-24	6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
ZA200110022B (en)	2003-05-28	Thiazoloderivatives and pharmaceutical compositions containing them.
AU2001269529A1 (en)	2002-01-30	Medicine comprising dicyanopyridine derivative
AU2001269508A1 (en)	2002-01-30	Drugs or cosmetics
AU5326100A (en)	2000-12-28	Pharmaceutical compositions and methods for use
AU2001269474A1 (en)	2002-04-18	Phenylpyridazine Compounds and Medicines Containing the Same
AU3556400A (en)	2000-10-04	Pharmaceutical compositions
AU1735001A (en)	2001-06-18	Cyclodextrin-containing pharmaceutical composition
AU1887401A (en)	2001-06-25	Medicinal composition
AU5565099A (en)	2000-05-08	Pharmaceutical compositions and methods for use
HUP0200055A3 (en)	2002-10-28	16-hydroxyestrienes and pharmaceutical compositions containing the same
AU1730201A (en)	2001-06-12	Proteoglycans and pharmaceutical compositions comprising them
AU6460400A (en)	2001-03-13	Pharmaceutical compositions
AU6196600A (en)	2001-07-16	Medication reminder system
AU2001294240A1 (en)	2002-04-22	2,2-diphenylbutanamide derivatives and medicines containing the same
AU2001232244A1 (en)	2001-08-20	Drug comprising combination
AU1466401A (en)	2001-05-14	Human transferase molecules
AU2001274535A1 (en)	2002-03-14	Hydroxyformamidine derivatives and medicines containing the same
AU6460200A (en)	2001-03-13	Pharmaceutical compositions
AU4085201A (en)	2001-09-24	Pharmaceutical composition
AU2001253521A1 (en)	2001-10-30	Haplotypes of the cxcr4 gene